课题基金 / 基金详情

The role of TET proteins in myeloid neoplasia

The role of TET proteins in myeloid neoplasia
TET蛋白在骨髓瘤形成中的作用
批准号:
172168220
负责人:
Professor Dr. Stefan Klaus Bohlander
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2011
资助国家:
德国
项目状态:
已结题
起止时间:
2010-12-31 至 2017-12-31

项目摘要

项目成果

Professor Dr. Stefan Klaus Bohlander的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DNA methylation plays a central role in epigenetic gene regulation duringdevelopment and disease. Recently, 5-hydroxymethyl-cytosine (5hmC) wasdiscovered as a novel type of DNA modification catalyzed by TET oxygenases.Mutations in TET genes, especially in TET2, were recently identified in patients with avariety of myeloid neoplasias. However, it is still completely unknown how thesemutation cause hematopoietic transformation. In this joint research project, we willstudy the expression of the TET genes during normal hematopoiesis and in patientderived material at the RNA and protein level. We will use biochemical assays for TETprotein function and test whether TET mutations can have a dominant negative effect.We generate cell line and animal models for the MLL/TET1 fusion gene and TET2mutations. These models will answer the question whether TET alterations per se areable to trigger hematopoietic transformation and will provide material to study theunderlying, molecular mechanisms. This joint research project uniquely combinespatient data, biochemical and cell biology assay with animal models and is expectedto provide insight into a novel epigenetic pathway and its role in myeloid neoplasia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functional Characterization of the CATS protein and its role in cellular proliferation and leukemogenesis
  • 批准号:
    62359487
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2008
  • 负责人:
    Professor Dr. Stefan Klaus Bohlander
  • 依托单位:
Etablierung eines transgenen Mausmodells für durch CALM/AF10 hervorgerufene Leukämien
Die Funktion der Gene ETV6 und STL bei der Leukämogenese
国内基金
海外基金
VRK1介导TET1磷酸化促进WIF1去甲基化缓解子宫内膜异位症的机制研究
  • 批准号:
    2026JJ82103
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘艺琪
  • 依托单位:
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究
TET1介导GLI3 mRNA m5C去甲基化修饰负调控ABCA1促动脉粥样硬化
  • 批准号:
    2026JJ81712
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    颜滢
  • 依托单位:
基于肌成纤维细胞成脂分化研究DNA双加氧酶TET2促进肺纤维化消退的作用及潜在机制
  • 批准号:
    2026JJ81678
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    李小红
  • 依托单位: